期刊
HEPATIC ONCOLOGY
卷 3, 期 4, 页码 223-239出版社
FUTURE MEDICINE LTD
DOI: 10.2217/hep-2016-0009
关键词
intrahepatic cholangiocarcinoma; liver cancer; outcome; prognosis; recurrence; surgical resection; survival; systemic therapy; tumor marker
类别
Intrahepatic cholangiocarcinoma (iCCA) is one of the fatal gastrointestinal cancers with increasing incidence and mortality. Although surgery offers the only potential for cure in iCCA patients, the prognosis is not optimal with low overall survival rate and high disease recurrence. Hence, adjuvant therapy is generally recommended in the management of high-risk patients. Identifying factors associated with disease recurrence and survival of the iCCA patients after resection will improve understanding of disease prognosis and help in selecting patients who will benefit from surgical resection or stratifying them for clinical trials. Despite development of new methods for early detection of tumor recurrence, effective prognostic models and nomograms, and recent advances in management, significant challenges remain in improving the prognosis of iCCA patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据